Launches PharmaOS as the Center’s first offering, taking clients from concept to validation in a week

Vikas Krishan, Chief Digital Business Officer and Head of UK and EMEA at Altimetrik, explains in The Fintech Times why rising AI usage does not guarantee better business outcomes. As organisations adopt agentic AI, he calls for clearer links between cost, value and ownership. He also argues that changes to EU AI Act timelines should […]

Altimetrik CEO Raj Sundaresan is featured in Newsweek, bringing our approach to AI, talent development and workplace culture to a global audience. Recognised among America’s Greatest Workplaces in Tech 2026, Altimetrik puts these commitments into practice through learning, experimentation and meaningful career opportunities. With more than 80% of our workforce having completed foundational AI training, […]

Ramji Vasudevan, Head of Health Care & Life Sciences at Altimetrik, writes in Pharmaceutical Market Europe about the need for clear accountability as pharma adopts AI. Drawing on HFS Research with Altimetrik, he argues that people reviewing AI recommendations need the knowledge and authority to question them. He identifies five foundations for effective governance: direction, authority, visibility, […]

As AI agents take on a larger role across the enterprise, traditional approaches to access and identity management need to evolve with them. In Forbes Technology Council, Niraj Nagrani- Chief Data & AI Officer, explains why zero trust must extend beyond human users to AI agents and service accounts, with least-privilege and short-lived access built […]

In an authored article for BankInfoSecurity Asia, Farid Roshan– Global Head, AI-Infused Digital, Altimetrik, explores why scaling engineers alone will not solve the enterprise AI challenge. The article examines why governance, security, observability and enterprise ownership must be built into this architecture from the start. The opportunity is not simply to adopt the biggest model, […]